Given that RT can reduce HbA1c, LDL, TG, and BP, and increase insulin sensitivity and HDL in T2D [27–32], the potential for RT to independently reduce the risk of T2D and CVD at an earlier stage should be further explored. This evidence concerns the gene INS and type 2 diabetes mellitus.